Supplementary Figure S8 from PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models
Authors:
- Dejan JuricDJDejan Juric
- Kyung SongKSKyung Song
- Radia M. JohnsonRJRadia M. Johnson
- Melissa K. AccordinoMAMelissa K. Accordino
- Philippe L. BedardPBPhilippe L. Bedard
- Andrés CervantesAndrés Cervantes
- Valentina GambardellaVGValentina Gambardella
- Erika HamiltonEHErika Hamilton
- Antoine ItalianoAntoine Italiano
- Kevin KalinskyKKKevin Kalinsky
- Ian E. KropIKIan E. Krop
- Mafalda OliveiraMafalda Oliveira
Open Access
- 6 January 2026
- other
- Published by American Association for Cancer Research (AACR)